206 related articles for article (PubMed ID: 36502328)
1. Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer's Disease.
Cheng ZZ; Gao F; Lv XY; Wang Q; Wu Y; Sun BL; Shen Y
J Alzheimers Dis; 2023; 91(2):795-804. PubMed ID: 36502328
[TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
[TBL] [Abstract][Full Text] [Related]
3. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
[TBL] [Abstract][Full Text] [Related]
4. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
[TBL] [Abstract][Full Text] [Related]
5. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers.
Kim SE; Kim HJ; Jang H; Weiner MW; DeCarli C; Na DL; Seo SW
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142419
[TBL] [Abstract][Full Text] [Related]
7. Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.
Ni M; Zhu ZH; Gao F; Dai LB; Lv XY; Wang Q; Zhu XX; Xie JK; Shen Y; Wang SC; Xie Q;
ACS Chem Neurosci; 2023 Jan; 14(1):170-179. PubMed ID: 36547971
[TBL] [Abstract][Full Text] [Related]
8. Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions.
Lv X; Zhang M; Cheng Z; Wang Q; Wang P; Xie Q; Ni M; Shen Y; Tang Q; Gao F;
Alzheimers Res Ther; 2023 Mar; 15(1):51. PubMed ID: 36915135
[TBL] [Abstract][Full Text] [Related]
9. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
10. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
Sun Y; Hu HY; Hu H; Huang LY; Tan L; Yu JT;
J Alzheimers Dis; 2023; 93(1):283-294. PubMed ID: 36970905
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes.
Ji Y; Li X; Teng Z; Li X; Jin W; Lv PY
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105393. PubMed ID: 33254368
[TBL] [Abstract][Full Text] [Related]
13. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
[TBL] [Abstract][Full Text] [Related]
14. Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
Wu C; Ma YH; Hu H; Zhao B; Tan L;
J Alzheimers Dis; 2023; 92(1):311-322. PubMed ID: 36744335
[TBL] [Abstract][Full Text] [Related]
15. Total Cerebral Small Vessel Disease Burden Is Related to Worse Performance on the Mini-Mental State Examination and Incident Dementia: A Prospective 5-Year Follow-Up.
Jiang Y; Wang Y; Yuan Z; Xu K; Zhang K; Zhu Z; Li P; Suo C; Tian W; Fan M; Jin L; Ye W; Dong Q; Cui M; Chen X
J Alzheimers Dis; 2019; 69(1):253-262. PubMed ID: 31006685
[TBL] [Abstract][Full Text] [Related]
16. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.
Jang H; Kim HJ; Choe YS; Kim SJ; Park S; Kim Y; Kim KW; Lyoo CH; Cho H; Ryu YH; Choi JY; DeCarli C; Na DL; Seo SW;
J Alzheimers Dis; 2020; 78(2):573-585. PubMed ID: 33016911
[TBL] [Abstract][Full Text] [Related]
19. The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease.
Cheng YW; Chiu MJ; Chen YF; Cheng TW; Lai YM; Chen TF
Alzheimers Res Ther; 2020 Aug; 12(1):91. PubMed ID: 32753051
[TBL] [Abstract][Full Text] [Related]
20. Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy.
Abner EL; Elahi FM; Jicha GA; Mustapic M; Al-Janabi O; Kramer JH; Kapogiannis D; Goetzl EJ
FASEB J; 2020 Apr; 34(4):5967-5974. PubMed ID: 32157747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
